Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-Imidazolyl)alkyl]-1(2H)-phthalazinones

M. YAMAGUCHI(Chugai Pharma (United States)), N. OHI, Michitaka Akima, Toshio Kuroki(Japan Society for the Promotion of Science), Takaki Koga, Kenshi Kamei
Journal of Medicinal Chemistry
December 1, 1993
Cited by 92


Related Papers